(Nasdaq:HBIO), a life sciences tools company, says the first two successful stem cells laryngotracheal transplants have been completed in Russia, using the company’s specially designed bioreactor to grow the stem cells, which were taken from the patients’ bone marrow.
View the original article here: Harvard Bioscience stem cells in Russian tracheal transplants – The Business Journal
 |
Infographics | More... |
30 years later in Romania: What happened to the babies deprived of human contact? 
Is tilapia a human-made freak that we should avoid — or an evolutionary rockstar? 
Evolution’s ‘great leap forward’: When did humans cross the intelligence rubicon? 
Embryos aren’t female by ‘default’ after all, study shows 
Viewpoint: Agribashing and the French media — Paper withdraws ‘fake news’ viral article claiming drinking water contains 200 ‘dangerous’ chemicals 
Gene-edited chickens could reduce the threat of bird flu spread and promote sustainability 
Why is it so difficult to find a treatment for Huntington’s Disease? 
Viewpoint: Iowa farmer explains support for state bill to restrict suits against manufacturers of glyphosate and other pesticides that follow federal guidelines 
Viewpoint: Why Greek organic-certified produce isn’t necessarily better or healthier than conventional food 
Viewpoint: The organic food industry is a $180 billion marketing fraud 
